Goldman Sachs
KALA icon

Goldman Sachs’s KALA BIO KALA Stock Holding History

Goldman Sachs’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.9K Buy
10,921
+10,640
+3,786% +$51.6K ﹤0.01% 6462
2026
Q1 		$2.43K Buy
+281
New +$5.94K ﹤0.01% 6418
2022
Q4 		– Sell
-4
Closed -$2K – 6137
2022
Q3 		$2K Sell
4
-94
-96% -$73.8K ﹤0.01% 6168
2022
Q2 		$74K Buy
98
+62
+172% +$97.3K ﹤0.01% 5939
2022
Q1 		$123K Sell
36
-45
-56% -$118K ﹤0.01% 6036
2021
Q4 		$246K Buy
81
+19
+31% +$88.2K ﹤0.01% 5782
2021
Q3 		$406K Sell
62
-2
-3% -$17.3K ﹤0.01% 5321
2021
Q2 		$852K Buy
64
+29
+83% +$456K ﹤0.01% 4878
2021
Q1 		$595K Buy
35
+16
+84% +$312K ﹤0.01% 4991
2020
Q4 		$318K Sell
19
-56
-75% -$1.05M ﹤0.01% 4858
2020
Q3 		$1.41M Sell
75
-52
-41% -$1.2M ﹤0.01% 3825
2020
Q2 		$3.34M Sell
127
-47
-27% -$1.33M ﹤0.01% 3088
2020
Q1 		$3.82M Buy
174
+147
+544% +$2.35M ﹤0.01% 2854
2019
Q4 		$248K Sell
27
-14
-34% -$135K ﹤0.01% 4822
2019
Q3 		$385K Buy
41
+30
+273% +$365K ﹤0.01% 4566
2019
Q2 		$175K Sell
11
-10
-48% -$166K ﹤0.01% 4831
2019
Q1 		$428K Sell
21
-7
-25% -$124K ﹤0.01% 4482
2018
Q4 		$347K Buy
28
+4
+17% +$69.3K ﹤0.01% 4560
2018
Q3 		$603K Buy
24
+11
+85% +$335K ﹤0.01% 4328
2018
Q2 		$449K Buy
13
+5
+63% +$192K ﹤0.01% 4575
2018
Q1 		$334K Buy
8
+3
+60% +$114K ﹤0.01% 4723
2017
Q4 		$235K Buy
+5
New +$234K ﹤0.01% 5331

Other funds holding KALA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs's KALA Position: Q2 2026 in Review

Goldman Sachs increased its KALA BIO (KALA) stake by 3,786% in Q2 2026, buying an estimated $51.6K and bringing the position to 10,921 shares worth $18.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6462.

Goldman Sachs first reported a position in KALA in Q4 2017 and has held it in 22 quarters since. The position peaked at $3.82M in Q1 2020. 14 funds tracked by Wall St. Rank hold KALA as of Q2 2026.

  • Goldman Sachs held 10,921 shares of KALA BIO worth $18.9K as of Q2 2026.
  • Goldman Sachs bought 10,640 KALA BIO shares in Q2 2026, an estimated $51.6K.
  • KALA BIO made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #6462 holding.
  • Goldman Sachs first reported a position in KALA BIO in Q4 2017 and has held it in 22 quarters since.
  • Goldman Sachs's KALA BIO position peaked at $3.82M in Q1 2020.
  • 14 funds tracked by Wall St. Rank held KALA BIO as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.